Dr. Walter Reinisch

Division of Gastroenterology

Dr. Walter Reinisch

MD

Professor (PT), Division of Gastroenterology, Department of Medicine

Chairholder, Audrey Campbell Chair in Ulcerative Colitis Research

Associate Professor, Gastroenterology, Division of Gastroenterology & Hepatology, Medical University of Vienna

 

 

Academic (or Research or Clinical) Interests

Dr. Reinisch, MD, graduated at the Medical University of Vienna (MUV), where he finished his training in Internal Medicine and Gastroenterology. After initial scientific studies in oncology at the MUV and the National Cancer Institute, Frederick, MD, he decided to focus his research interest on inflammatory Bowel disease (IBD). Dr. Reinisch is founding member of the European Crohn’s & Colitis Organisation (ECCO) and was assigned as honorary member after having contributed in various positions. He was active in the Scientific and Public Affairs Committee of the United European Gastroenterology (UEG) and headed the Austrian IBD Study Group. Dr. Reinisch is member of the International Organization For the Study of Inflammatory Bowel Disease (IOIBD).

Dr. Reinisch is an expert in designing, conducting and interpreting the results of clinical trials in IBD. He envisions a customized management of IBD utilizing the innovations of translational medicine. He advocates the implementation of a "common language of inflammatory bowel disease" to improve the communication with patients and between physicians for a better care and more robust research outcomes.

Selected Publications

  1. Reinisch W, Staun M, Tandon RK, Altorjay I, Thillainayagam AV, Gratzer C, Nijhawan S, Thomsen LL. A Randomized, Open-Label, Non-Inferiority Study of Intravenous Iron Isomaltoside 1,000 (Monofer) Compared With Oral Iron for Treatment of Anemia in IBD (PROCEED). Am J Gastroenterol. 2013 Oct 22. doi: 10.1038/ajg.2013.335. [Epub ahead of print] PubMed PMID: 24145678.
  2. Reinisch W, Chowers Y, Danese S, Dignass A, Gomollón F, Haagen Nielsen O, Lakatos PL, Lees CW, Lindgren S, Lukas M, Mantzaris GJ, Michetti P, Moum B, Peyrin-Biroulet L, Toruner M, van der Woude J, Weiss G, Stoevelaar H. The management of iron deficiency in inflammatory bowel disease - an online tool developed by the RAND/UCLA appropriateness method. Aliment Pharmacol Ther. 2013 Nov;38(9):1109-18. doi: 10.1111/apt.12493. Epub 2013 Sep 17. PubMed PMID: 24099472.
  3. li>
  4. Angelberger S, Reinisch W, Makristathis A, Lichtenberger C, Dejaco C, Papay P, Novacek G, Trauner M, Loy A, Berry D. Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation. Am J Gastroenterol. 2013 Oct;108(10):1620-30. doi: 10.1038/ajg.2013.257. Epub 2013 Sep 24. PubMed PMID: 24060759.
  5. Novacek G, Haas T, Knoflach P, Petritsch W, Tilg H, Vogelsang H, Reinisch W. [Adalimumab for the treatment of adult Crohn's disease--update of a consensus report by the Working Group Inflammatory Bowel Disease of the Austrian Society of Gastroenterology and Hepatology]. Z Gastroenterol. 2013 Sep;51(9):1101-9. doi: 10.1055/s-0033-1350165. Epub 2013 Aug 30. German. Erratum in: Z Gastroenterol. 2013 Sep;51(9):E2. PubMed PMID: 23996653.
  6. Peyrin-Biroulet L, Reinisch W, Colombel JF, Mantzaris GJ, Kornbluth A, Diamond R, Rutgeerts P, Tang LK, Cornillie FJ, Sandborn WJ. Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial. Gut. 2013 Aug 23. doi: 10.1136/gutjnl-2013-304984. [Epub ahead of print] PubMed PMID: 23974954.